European Companies Search Engine
Shareholder agreement · Corporate Purpose Hrb4 Jul 2018 German Trade Register Announcements, Germany (28/06/2018)
Overview
Text
HRB 200051: Vakzine Projekt Management GmbH,
Unnamed street ??, 30625 Hannover, Germany
. The Shareholders' Meeting of June 25, 2018 decided to recast the company contract and with it to change the object of the company. New business objective: the further development and exploitation of research results, technologies and products in the field of vaccines as well a.s. the advice and support of research institutions and industry in this field. The subject matter includes the manufacture of pharmaceutical and biotechnology products and their research and development either on their own basis or on the basis of licensing of technologies or otherwise, including the trade in intellectual property rights.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Serum Life Science Europe GmbH, Hanover, Germany.